Plus Therapeutics Inc (NASDAQ:PSTV) traded at $1.02 at close of the session on Tuesday, April 01 and made an upward move of 7.36% on its previous day’s price.
Looking at the stock we see that its previous close was $0.95 and the beta (5Y monthly) reads 0.731 with the day’s price range being $0.97 – $1.08. In terms of its 52-week price range, PSTV has a high of $2.67 and a low of $0.24. The company’s stock has gained about 54.55% over that past 30 days.
Plus Therapeutics Inc has a market cap of $12.02 million and is expected to release its quarterly earnings report on 2025-Mar-26.
On the other hand, looking at the outlook for the PSTV stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is -5.57% off its SMA20 and -7.25% from its 50-day simple moving average. The RSI (14) is pointing at 48.66 while the volatility over the past week is 18.81% and jumps to 58.84% over the past one month. The beta value is 0.67, while the average true range (ATR) is currently pointing at 0.33.
Coming back to Plus Therapeutics Inc (NASDAQ:PSTV), we note that the average 3-month trading volume was 16.25 million, while that of the preceding 10-day period stands at 46.05 million. Current shares outstanding are 11.79 million.
The insiders hold 2.55% of the company’s shares while institutions hold 16.02%. The data shows that short shares as of 2025-03-14, stood at 0.93 million at a short ratio of 0.04. This represents a 1607.00 short interest in shares outstanding on 2025-03-14. Shares short rose in March from the previous month at 59847.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -11.30% down in year-to-date price movement.
